Skip to content

Clinical evaluation of early application of Suxiao Jiuxin pills in ACS patients with chest pain center

Clinical evaluation of early application of Suxiao Jiuxin pills in ACS patients with chest pain center

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2024000625
Enrollment
Unknown
Registered
2024-10-30
Start date
2024-05-13
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndrome

Interventions

Control group:Take Nitroglycerin

Sponsors

Tianjin Chest Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1) 120 patients/primary hospital/emergency department; 2) Meets the diagnostic criteria for ACS in Western points; 3) Gender not limited, duration of illness not limited,.

Exclusion criteria

Exclusion criteria: 1) Patients with severe symptoms but poor control effects, such as those diagnosed with heart failure, cardiomyopathy, myocarditis, severe metabolic diseases, malignant tumors, severe liver failure, or renal failure; 2) Patients with cognitive impairment or diagnosed with mental illness; 3) The patient has an allergic constitution or is clearly allergic to the treatment drug studied in this study; 4) Patients with poor compliance or who may not be able to attend the visit as planned; 5) The researchers believe that there may be situations other than those mentioned above that are not suitable for participating in the experiment; 6) Nitroglycerin is contraindicated for acute inferior wall and right ventricular myocardial infarction.

Design outcomes

Primary

MeasureTime frame
Clinical efficacy evaluation of angina pectoris;

Secondary

MeasureTime frame
Vascular recanalization status;Clinical efficacy evaluation of electrocardiogram;Mortality;CCS Class;Assessment of Chest Pain Visual Analog Scale (VAS);Frequency of angina attacks;

Countries

China

Contacts

Public ContactLi Chunjie

Tianjin Chest Hospital

Lichunjie0227@126.com13820600988

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026